A nurse is caring for a patient receiving high-dose methotrexate chemotherapy. Which nursing intervention is the MOST critical to prevent life-threatening complications?

High-dose methotrexate chemotherapy carries significant risks that require careful nursing management to prevent life-threatening complications. Methotrexate is an antimetabolite that inhibits dihydrofolate reductase, blocking DNA synthesis in rapidly dividing cells. While this mechanism effectively targets cancer cells, it also affects normal rapidly dividing cells, potentially causing severe toxicity.

The most critical safety intervention is ensuring adequate hydration and urine alkalinization. High-dose methotrexate can precipitate in the kidneys, forming crystals and causing acute renal failure. This nephrotoxicity occurs because methotrexate and its metabolites have low solubility in acidic urine. Maintaining urine pH above 7.0 (typically using sodium bicarbonate) dramatically increases methotrexate solubility, preventing crystal formation and subsequent kidney damage.

Aggressive hydration (typically 3-4L per day) ensures adequate urine output and helps flush methotrexate through the kidneys. The combination of hydration and alkalinization is essential because if renal failure develops, methotrexate clearance is delayed, leading to prolonged exposure and increased toxicity to other organs. This intervention is the highest priority because it directly prevents the most immediate life-threatening complication.

Leucovorin (folinic acid) rescue is also administered to counteract methotrexate's effects on normal cells, but this question focuses on nursing interventions rather than medication administration protocols.